Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takayuki Inomata

Showing results (21-30 of 158) with videos related to

Pageof 16
Sort By:
Clinical Neuroradiology|May 30, 2024
Clinical Use of Hematoma Volume Based On Automated Segmentation of Chronic Subdural Hematoma Using 3D U-NetTakayuki Inomata, Koji Nakaya, Mikio Matsuhiro, et al.
Journal of Cardiac Failure|February 28, 2002
Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failureMinako Yamaoka-Tojo, Taiki Tojo, Takayuki Inomata, et al.
Internal Medicine (Tokyo, Japan)|May 9, 2006
Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failureMinako Yamaoka-Tojo, Taiki Tojo, Tetsuo Shioi, et al.
International Heart Journal|March 6, 2015
Effectiveness and adverse events of tolvaptan in octogenarians with heart failure. Interim analyses of Samsca Post-Marketing Surveillance In Heart faiLurE (SMILE study)Koichiro Kinugawa, Takayuki Inomata, Naoki Sato, et al.
International Heart Journal|December 1, 2024
Cost-Effectiveness Analysis of Adding Ivabradine to Current Standard Therapy Versus Standard Therapy Alone in Patients with Chronic Heart Failure in JapanTakayuki Inomata, Takeshi Fukuda, Nobuya Yamashita, et al.
International Heart Journal|January 24, 2017
Who Needs Longer Tolvaptan Treatment?Koichiro Kinugawa, Takayuki Inomata, Naoki Sato, et al.
Plos One|February 25, 2025
Cardiology involvement and mortality in adult patients with advanced solid cancer complicated by atrial fibrillationTakeshi Sato, Zhehao Dai, Jun Hashimoto, et al.
Heart and Vessels|September 28, 2018
Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STARYuki Ikeda, Takayuki Inomata, Keisuke Kida, et al.
Internal Medicine (Tokyo, Japan)|February 25, 2024
Coronary Aneurysm after Excimer Laser Catheter Ablation and Plain Balloon Angioplasty for Chronic Total Occlusion in a Patient with Kawasaki DiseaseMakoto Hoyano, Kazuyuki Ozaki, Naoki Kubota, et al.
International Heart Journal|April 6, 2007
Clinical usefulness of electrophysiologic study (EPS)-guided risk stratification for life-threatening arrhythmia in patients with heart failureSae Sasaki, Shinichi Niwano, Hidehira Fukaya, et al.
Pageof 16

Showing results (21-30 of 158) with videos related to

Sort By:
Pageof 16
Clinical Neuroradiology|May 30, 2024
Clinical Use of Hematoma Volume Based On Automated Segmentation of Chronic Subdural Hematoma Using 3D U-NetTakayuki Inomata, Koji Nakaya, Mikio Matsuhiro, et al.
Journal of Cardiac Failure|February 28, 2002
Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failureMinako Yamaoka-Tojo, Taiki Tojo, Takayuki Inomata, et al.
Internal Medicine (Tokyo, Japan)|May 9, 2006
Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failureMinako Yamaoka-Tojo, Taiki Tojo, Tetsuo Shioi, et al.
International Heart Journal|March 6, 2015
Effectiveness and adverse events of tolvaptan in octogenarians with heart failure. Interim analyses of Samsca Post-Marketing Surveillance In Heart faiLurE (SMILE study)Koichiro Kinugawa, Takayuki Inomata, Naoki Sato, et al.
International Heart Journal|December 1, 2024
Cost-Effectiveness Analysis of Adding Ivabradine to Current Standard Therapy Versus Standard Therapy Alone in Patients with Chronic Heart Failure in JapanTakayuki Inomata, Takeshi Fukuda, Nobuya Yamashita, et al.
International Heart Journal|January 24, 2017
Who Needs Longer Tolvaptan Treatment?Koichiro Kinugawa, Takayuki Inomata, Naoki Sato, et al.
Plos One|February 25, 2025
Cardiology involvement and mortality in adult patients with advanced solid cancer complicated by atrial fibrillationTakeshi Sato, Zhehao Dai, Jun Hashimoto, et al.
Heart and Vessels|September 28, 2018
Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STARYuki Ikeda, Takayuki Inomata, Keisuke Kida, et al.
Internal Medicine (Tokyo, Japan)|February 25, 2024
Coronary Aneurysm after Excimer Laser Catheter Ablation and Plain Balloon Angioplasty for Chronic Total Occlusion in a Patient with Kawasaki DiseaseMakoto Hoyano, Kazuyuki Ozaki, Naoki Kubota, et al.
International Heart Journal|April 6, 2007
Clinical usefulness of electrophysiologic study (EPS)-guided risk stratification for life-threatening arrhythmia in patients with heart failureSae Sasaki, Shinichi Niwano, Hidehira Fukaya, et al.
Pageof 16